Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title
tabling member	label

Search

100402

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Paralysis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to support University College London in its work to enable people who have been paralysed to regain the ability to walk.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	211576
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The Department’s National Institute for Health Research (NIHR) funds 11 biomedical research centres that conduct translational research to transform scientific breakthroughs into benefits for patients. These centres are formed through partnerships between England’s leading National Health Service organisations and universities.</p><p> </p><p> </p><p> </p><p>The NIHR is investing £110 million over five years (2012-17) in the NIHR biomedical research centre at University College London Hospitals NHS Foundation Trust and University College London. The centre is supporting research on the use of cells from the lining of the nose to repair damaged nerves in the spinal cord.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/10/2014 16:53:22 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

100403

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Perinatal Mortality
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the NHS takes to assist mothers of stillborn children to come to terms with their grief.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	211575
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The National Health Service locally should ensure that appropriate facilities and services are in place to support bereaved parents following the death of a baby. In line with the Nursing and Midwifery Council’s Standards of proficiency for pre-registration midwifery education, all midwives should be proficient in providing care for women who have suffered pregnancy loss, stillbirth or neonatal death. Health Education England has agreed to work with partners to ensure that pre and post registration training in perinatal mental health is available to enable specialist staff to be available to every birthing unit by 2017.</p><p>To assist NHS commissioners and providers, the Royal College of Obstetricians and Gynaecologists’ Standards for Gynaecology and Standards for Maternity sets out clear standards for the level of care provided to help women and their partners experiencing pregnancy loss, including the availability of skilled staff to support parents following a stillbirth or miscarriage. A number of trusts now employ specialist bereavement midwives to provide this support.</p><p>To further assist NHS maternity services, NHS Improving Quality published ‘A review of support available for loss in early and late pregnancy’ in February 2014, which highlights areas of good practice and additional sources of support, such as the stillbirth and neonatal death charity, Sands.</p><p>Local NHS maternity care providers are responsible for ensuring parents receive appropriate information on bereavement support and services following the death of a baby. To complement information provided locally, information on support for parents after a stillbirth is available on the NHS Choices website at:</p><p>www.nhs.uk/Conditions/Stillbirth/Pages/Getting-help.aspx</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/10/2014 16:51:15 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4131 label Biography information for Jim Shannon

100406

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Vacancies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to ensure that as many staff vacancies in the NHS as possible are filled by citizens of the UK.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	211577
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>In filling their vacancies, employers across the National Health Service in England are required to comply with employment law and ensure all applicants including citizens of, and others who demonstrate they are eligible to work in, the United Kingdom, are treated fairly and consistently.</p><p> </p><p> </p><p> </p><p>Health Education England<sup><sup>[1]</sup></sup> has been tasked with reducing the number of health roles on the Home Office Shortage Occupation List by March 2015. Where roles remain on the list an action plan should be produced to ensure that work is done to ensure that they can be removed.</p><p> </p><br /><p>[1] ”Delivering high quality effective, compassionate care: Developing the right people with the right skills and right values”- A Mandate to Health Education England: April 2014 to March 2015</p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/10/2014 16:47:06 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4131 label Biography information for Jim Shannon

100411

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cystic Fibrosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to support research into new treatments for people with cystic fibrosis.
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	211584
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The National Institute for Health Research (NIHR) Evaluation, Trials and Studies Coordinating Centre manages the Efficacy and Mechanism Evaluation programme. With funding from the Medical Research Council, this programme is currently supporting a £3.3 million trial of repeated application of gene therapy in patients with cystic fibrosis. The report of this trial is expected to be published in August 2015.</p><p> </p><p><strong> </strong></p><p> </p><p>A range of commercial and researcher-led cystic fibrosis treatment trials and studies are hosted by NIHR research infrastructure including the NIHR Clinical Research Network, NIHR biomedical research centres and units, and NIHR clinical research facilities for experimental medicine.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/10/2014 16:52:12 answering member 4020 label Biography information for George Freeman
tabling member	4243 label Biography information for Dan Jarvis

100414

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many cases relating to contaminated blood were brought against the NHS Litigation Authority in each of the last three years; and how many such cases were successful.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211590
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>No cases relating to contaminated blood have been brought against the National Health Service under any of the NHS Litigation Authority’s indemnity schemes in the last three years.</p><p> </p><p> </p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/10/2014 16:45:15 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4036 label Biography information for Luciana Berger

100416

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hospital Wards: Gender
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the requirement to eliminate mixed sex accommodation in NHS trusts on perinatal mother and baby units.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	211591
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>We are not aware that the elimination of mixed sex accommodation has had any effect on perinatal mother and baby units.</p><p> </p><p> </p><p> </p><p>This Government introduced the first ever publication of data on breaches of same sex accommodation guidance, and since then the number of reported breaches of that guidance has fallen by around 98% (from over 11,000 in December 2010 to 141 in September 2014).</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/10/2014 16:48:38 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4036 label Biography information for Luciana Berger

100494

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Young Offender Institutions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to (a) treat and (b) prevent depression in young offenders institutions.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	211570
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>NHS England has responsibility for commissioning health services in young offenders’ institutions (YOIs). NHS England has worked closely with the Royal Colleges of Paediatrics and Child Health; General Practitioners; Nursing; Psychiatrists and Forensic Medicine and has used their standards for children and young people in secure settings as a basis for national service specifications for the health services commissioned in YOIs.</p><p> </p><p> </p><p> </p><p>A key component of this is that the service should deliver child and adolescent mental health services (CAMHS) which meet the emotional and mental health needs of children and young people accommodated within the secure setting, based on clinical need. Children in secure settings are entitled to service provision that is equivalent to that available for children living in the wider community, within the constraints of the secure environment.</p><p> </p><p> </p><p> </p><p>CAMHS cover early intervention, mental health promotion, prevention and treatment for the full range of mental health needs and care after discharge from a secure placement, including transfer to inpatient or adult services.</p><p> </p><p> </p><p> </p><p>The CHAT (Comprehensive Health Assessment Tool) is used as a health screen for all children and young people entering the secure estate to assess individual health need and identify those needing a full mental health assessment.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 27/10/2014 16:56:44 answering member 1439 label Biography information for Norman Lamb
tabling member	308 label Biography information for Mr Jim Cunningham

100196

registered interest
date	21/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Radiotherapy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether the signature authorising Individual Funding Requests made to NHS England for Gamma Knife treatment by University College Hospital London, Queen Square, is that of a senior clinician employed by University College Hospital London.
tabling member constituency	Wells
tabling member printed	Tessa Munt
uin	211310
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>We are advised by NHS England that the clinician who authorises Individual Funding Requests for Gamma Knife treatment to be undertaken at the Queens Square Radiology Centre Ltd (QSRC) is a surgeon at the National Hospital for Neurosurgery and Neurology (NHNN), part of University College London Hospitals NHS Foundation Trust (UCLH).</p><p> </p><p> </p><p> </p><p>Gamma Knife treatment is not undertaken by UCLH but by the private company QSRC, which is based at NHNN but has no formal relationship with UCLH.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:54:23 answering member 3918 label Biography information for Jane Ellison
tabling member	4089 label Biography information for Tessa Munt

99850

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Medical Equipment: West Midlands
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will take steps to ensure the routine commissioning of cough assist machines in the West Midlands.
tabling member constituency	Sutton Coldfield
tabling member printed	Mr Andrew Mitchell
uin	211129
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>Since 1 April 2013, NHS England has been responsible for commissioning specialised neurological services, which includes services for patients with neuromuscular disorders, such as muscular dystrophy. NHS England has published a neurosciences specification, which sets out what providers must have in place to offer high quality care and treatment for patients.</p><p> </p><p> </p><p> </p><p>The neurosciences service specification describes when patients should be referred to specialist respiratory services and the circumstances in which cough assist devices should be considered. It is available from the NHS England website at this link:</p><p> </p><p> </p><p> </p><p>http://www.england.nhs.uk/wp-content/uploads/2013/06/d04-neurosci-spec-neuro.pdf.</p><p> </p><p> </p><p> </p><p>A copy of this document has also been attached.</p><p> </p><p> </p><p> </p><p>The equipment and respiratory support of cough assist is the commissioning responsibility of clinical commissioning groups, delivered through local specialist respiratory services, according to any local clinical commissioning policy they may have in place.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 16:43:52 answering member 3918 label Biography information for Jane Ellison attachment 1 file name NHS England neuroscience service specification.pdf title Neurosciences service specification
tabling member	1211 label Biography information for Mr Andrew Mitchell

99857

registered interest
date	20/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many (a) first-stage payments and (b) second-stage payments have been made from the Skipton Fund to the estates of individuals who contracted hepatitis C following NHS treatment with blood products between 1970 and 1995 but who died before 29 August 2003; what the total amount of money paid out to these estates was; how many total applications for lump sum payments were made by the families and dependants of these victims from 10 January to the end of March 2011; how many applications were refused on the basis that they came in too late; whether his Department has received any representations from (i) the families of victims, (ii) campaign groups and (iii) the Skipton Fund or Caxton Foundation about the time available to apply.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211080
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The following table sets out the number of payments and total paid out by Skipton Fund Ltd to the estates of individuals who contracted hepatitis C through treatment with NHS supplied blood or blood products prior to 1991 and who died prior to 29 August 2003.</p><p> </p><p> </p><p> </p><table><tbody><tr><td rowspan="2"><p> </p></td><td colspan="2"><p>(a) Stage 1</p></td><td colspan="2"><p>(b) Of whom have also received Stage 2*</p></td></tr><tr><td><p>Number of payments</p></td><td><p>Total cost (£)</p></td><td><p>Number of payments</p></td><td><p>Total cost (£)</p></td></tr><tr><td><p>For all individuals</p></td><td><p>472</p></td><td><p>9,440,000.00</p></td><td><p>258</p></td><td><p>12,900,000.00</p></td></tr><tr><td><p>Comprising individuals with a bleeding disorder treated with plasma derived products</p></td><td><p>441</p></td><td><p>8,820,000.00</p></td><td><p>236</p></td><td><p>11,800,000.00</p></td></tr><tr><td><p>And individuals treated with a whole blood transfusion</p></td><td><p>31</p></td><td><p>620,000.00</p></td><td><p>22</p></td><td><p>1,100,000.00</p></td></tr></tbody></table><p> </p><p>*Stage 2 payment is made for individuals who received a stage 1 payment and progressed to more severe hepatitis C related disease.</p><p> </p><p> </p><p> </p><p>There were 81 such applications before 31 March 2011. However, the deadline initially set of 31 March 2011 was for registrations with the Skipton Fund and not completed applications. No applications have been refused to date for missing the deadline.</p><p> </p><p> </p><p> </p><p>The Department received representations from campaign groups and families of deceased individuals in relation to the deadline, and worked with the Skipton Fund in 2011 to agree that any late registrations would be processed, provided the individual registering had good reason for the late registration.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 27/10/2014 17:01:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson